AEON Biopharma, Inc. (AEON)

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $9.62 million. The enterprise value is $25.59 million.

Market Cap	9.62M
Enterprise Value	25.59M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 79.97 million shares outstanding. The number of shares has decreased by -66.29% in one year.

Current Share Class	79.97M
Shares Outstanding	79.97M
Shares Change (YoY)	-66.29%
Shares Change (QoQ)	+1.73%
Owned by Insiders (%)	3.03%
Owned by Institutions (%)	31.93%
Float	52.51M

Valuation Ratios

The trailing PE ratio is 0.35.

PE Ratio	0.35
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.30
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.87
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.22

Current Ratio	0.22
Quick Ratio	0.05
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-194.80%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	501.29%
Revenue Per Employee	n/a
Profits Per Employee	$1.37M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.87% in the last 52 weeks. The beta is 0.05, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-98.87%
50-Day Moving Average	0.32
200-Day Moving Average	0.96
Relative Strength Index (RSI)	34.86
Average Volume (20 Days)	6,943,071

Short Selling Information

The latest short interest is 2.98 million, so 3.72% of the outstanding shares have been sold short.

Short Interest	2.98M
Short Previous Month	61,092
Short % of Shares Out	3.72%
Short % of Float	5.67%
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.70M
Pretax Income	-323.95M
Net Income	13.68M
EBITDA	-33.60M
EBIT	-33.70M
Earnings Per Share (EPS)	$0.34

Balance Sheet

The company has $537,000 in cash and $16.50 million in debt, giving a net cash position of -$15.97 million or -$0.20 per share.

Cash & Cash Equivalents	537,000
Total Debt	16.50M
Net Cash	-15.97M
Net Cash Per Share	-$0.20
Equity (Book Value)	-32.09M
Book Value Per Share	-0.81
Working Capital	-8.36M

Cash Flow

Operating Cash Flow	-30.69M
Capital Expenditures	n/a
Free Cash Flow	-30.69M
FCF Per Share	-$0.38

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	66.29%
Shareholder Yield	66.29%
Earnings Yield	142.20%
FCF Yield	-319.01%

Analyst Forecast

The average price target for AEON Biopharma is $5.00, which is 4,056.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	4,056.28%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1